Douglas Beck's Net Worth
-$84.6 Thousand
Who is Douglas Beck?
Douglas Beck does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Lev Pharmaceuticals Inc, DIVERSIFIED SECURITY SOLUTIONS INC, RELMADA THERAPEUTICS, INC., AIT Therapeutics, Inc., iBio, Inc., and ShiftPixy, Inc..
SEC CIK
Douglas Beck's CIK is 0001267110
Past Insider Trading and Trends
2019 was Douglas Beck's most active year for acquiring shares with 5 total transactions. Douglas Beck's most active month to acquire stocks was the month of October. 2004 was Douglas Beck's most active year for disposing of shares, totalling 2 transactions. Douglas Beck's most active month to dispose stocks was the month of May. 2015 saw Douglas Beck paying a total of $67,500.00 for 25,000 shares, this is the most they've acquired in one year. In 2004 Douglas Beck cashed out on 200 shares for a total of $832.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Lev Pharmaceuticals Inc No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DIVERSIFIED SECURITY SOLUTIONS INC No price found
Acting Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$7.54 | -$157.00 |
0
|
Jun 22
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RELMADA THERAPEUTICS, INC. (RLMD) Snapshot price: $2.68
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AIT Therapeutics, Inc. (XAIR) Snapshot price: $0.428
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.66% | 1K |
$5.38 | $5,380.00 | 22.46K |
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4/A
| +19.40% | 3K |
$4.88 | $14,640.00 | 18.46K |
Sep 24
| |||
Form 4
| +16.25% | 3K |
$5.28 | $15,840.00 | 21.46K |
Dec 31
| |||
Form 4
| +4.86% | 3K |
$4.88 | $14,640.00 | 64.71K |
Sep 24
| |||
Form 4
| +11.30% | 1.57K |
$3.98 | $6,244.62 | 15.46K |
Nov 13
| |||
Form 4
| +43.06% | 4.18K |
$4.05 | $16,937.56 | 13.89K |
Nov 8 - Nov 13
| |||
Form 4
|
∞
| 9.71K |
$5.15 | $50,006.50 | 9.71K |
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
iBio, Inc. (IBIO) Snapshot price: $1.75
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||